Cargando…
Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population
BACKGROUND: The present study aimed to clarify the effects of four inflammatory indicators (monocyte-to-high-density lipoprotein ratio [MHR], neutrophil-to-lymphocyte ratio [NLR], systematic immune-inflammation index [SII], and systemic inflammation response index [SIRI]) in evaluating the risk of m...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500229/ https://www.ncbi.nlm.nih.gov/pubmed/36157453 http://dx.doi.org/10.3389/fendo.2022.944991 |
_version_ | 1784795171198599168 |
---|---|
author | Wang, Pengbo Guo, Xiaofan Zhou, Ying Li, Zhao Yu, Shasha Sun, Yingxian Hua, Yu |
author_facet | Wang, Pengbo Guo, Xiaofan Zhou, Ying Li, Zhao Yu, Shasha Sun, Yingxian Hua, Yu |
author_sort | Wang, Pengbo |
collection | PubMed |
description | BACKGROUND: The present study aimed to clarify the effects of four inflammatory indicators (monocyte-to-high-density lipoprotein ratio [MHR], neutrophil-to-lymphocyte ratio [NLR], systematic immune-inflammation index [SII], and systemic inflammation response index [SIRI]) in evaluating the risk of metabolic diseases and cardiovascular disease (CVD), filling the gap of inflammation-metabolism system research in epidemiology. METHODS: We conducted a cross-sectional study and multivariable logistic regression analysis to elucidate the association between inflammatory indicators and metabolic diseases and CVD risk. Metabolic diseases were defined as metabolic disorders (MetDs) or their components, such as metabolic syndrome (MetS), dyslipidemia, and central obesity. We calculated the Framingham risk score (FRS) to evaluate 10-year CVD risk. RESULTS: Odds ratios for the third vs. the first tertile of MHR were 2.653 (95% confidence interval [CI], 2.142–3.286) for MetD, 2.091 (95% CI, 1.620–2.698) for MetS, 1.547 (95% CI, 1.287–1.859) for dyslipidemia, and 1.515 (95% CI, 1.389–1.652) for central obesity. Odds ratios for the third vs. the first tertile of SIRI were 2.092 (95% CI, 1.622–2.699) for MetD, 3.441 (95% CI, 2.917–4.058) for MetS, 1.417 (95% CI, 1.218–1.649) for dyslipidemia, and 2.080 (95% CI, 1.613–2.683) for central obesity. The odds ratio of a 10-year CVD risk of >30% for the third vs. the first tertile of MHR was 4.607 (95% CI, 2.648–8.017) and 3.397 (95% CI, 1.958–5.849) for SIRI. CONCLUSIONS: MHR and SIRI had a significant association with MetD and its components, in which a higher level of MHR or SIRI tended to accompany a higher risk of metabolic diseases. Furthermore, they also correlated with CVD, and the increment of these indicators caused a gradually evaluated risk of 10-year CVD risk. |
format | Online Article Text |
id | pubmed-9500229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95002292022-09-24 Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population Wang, Pengbo Guo, Xiaofan Zhou, Ying Li, Zhao Yu, Shasha Sun, Yingxian Hua, Yu Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The present study aimed to clarify the effects of four inflammatory indicators (monocyte-to-high-density lipoprotein ratio [MHR], neutrophil-to-lymphocyte ratio [NLR], systematic immune-inflammation index [SII], and systemic inflammation response index [SIRI]) in evaluating the risk of metabolic diseases and cardiovascular disease (CVD), filling the gap of inflammation-metabolism system research in epidemiology. METHODS: We conducted a cross-sectional study and multivariable logistic regression analysis to elucidate the association between inflammatory indicators and metabolic diseases and CVD risk. Metabolic diseases were defined as metabolic disorders (MetDs) or their components, such as metabolic syndrome (MetS), dyslipidemia, and central obesity. We calculated the Framingham risk score (FRS) to evaluate 10-year CVD risk. RESULTS: Odds ratios for the third vs. the first tertile of MHR were 2.653 (95% confidence interval [CI], 2.142–3.286) for MetD, 2.091 (95% CI, 1.620–2.698) for MetS, 1.547 (95% CI, 1.287–1.859) for dyslipidemia, and 1.515 (95% CI, 1.389–1.652) for central obesity. Odds ratios for the third vs. the first tertile of SIRI were 2.092 (95% CI, 1.622–2.699) for MetD, 3.441 (95% CI, 2.917–4.058) for MetS, 1.417 (95% CI, 1.218–1.649) for dyslipidemia, and 2.080 (95% CI, 1.613–2.683) for central obesity. The odds ratio of a 10-year CVD risk of >30% for the third vs. the first tertile of MHR was 4.607 (95% CI, 2.648–8.017) and 3.397 (95% CI, 1.958–5.849) for SIRI. CONCLUSIONS: MHR and SIRI had a significant association with MetD and its components, in which a higher level of MHR or SIRI tended to accompany a higher risk of metabolic diseases. Furthermore, they also correlated with CVD, and the increment of these indicators caused a gradually evaluated risk of 10-year CVD risk. Frontiers Media S.A. 2022-09-09 /pmc/articles/PMC9500229/ /pubmed/36157453 http://dx.doi.org/10.3389/fendo.2022.944991 Text en Copyright © 2022 Wang, Guo, Zhou, Li, Yu, Sun and Hua https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Wang, Pengbo Guo, Xiaofan Zhou, Ying Li, Zhao Yu, Shasha Sun, Yingxian Hua, Yu Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population |
title | Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population |
title_full | Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population |
title_fullStr | Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population |
title_full_unstemmed | Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population |
title_short | Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population |
title_sort | monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500229/ https://www.ncbi.nlm.nih.gov/pubmed/36157453 http://dx.doi.org/10.3389/fendo.2022.944991 |
work_keys_str_mv | AT wangpengbo monocytetohighdensitylipoproteinratioandsystemicinflammationresponseindexareassociatedwiththeriskofmetabolicdisordersandcardiovasculardiseasesingeneralruralpopulation AT guoxiaofan monocytetohighdensitylipoproteinratioandsystemicinflammationresponseindexareassociatedwiththeriskofmetabolicdisordersandcardiovasculardiseasesingeneralruralpopulation AT zhouying monocytetohighdensitylipoproteinratioandsystemicinflammationresponseindexareassociatedwiththeriskofmetabolicdisordersandcardiovasculardiseasesingeneralruralpopulation AT lizhao monocytetohighdensitylipoproteinratioandsystemicinflammationresponseindexareassociatedwiththeriskofmetabolicdisordersandcardiovasculardiseasesingeneralruralpopulation AT yushasha monocytetohighdensitylipoproteinratioandsystemicinflammationresponseindexareassociatedwiththeriskofmetabolicdisordersandcardiovasculardiseasesingeneralruralpopulation AT sunyingxian monocytetohighdensitylipoproteinratioandsystemicinflammationresponseindexareassociatedwiththeriskofmetabolicdisordersandcardiovasculardiseasesingeneralruralpopulation AT huayu monocytetohighdensitylipoproteinratioandsystemicinflammationresponseindexareassociatedwiththeriskofmetabolicdisordersandcardiovasculardiseasesingeneralruralpopulation |